Sarda Proteins Ltd — Important, 18-03-2026: Company Update

Sarda Proteins' Board has approved the conversion of 72,50,000 convertible warrants into an equal number of equity shares. This follows the receipt of Rs. 62.53 crore from warrant holders, completing their payment at Rs. 115 per warrant. As a result, the company's paid-up equity share capital has increased to approximately Rs. 8.98 crore, comprising 89,75,900 shares. This move strengthens the company's capital base and converts previously issued warrants into permanent equity.